Skip to content
10-Q

Quarterly Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-11-006086

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 10, 2011 38.15M sh
Shares Diluted Q3 2011 · Sep 30, 2011 38.15M sh
Shares Diluted Q3 2011 · Sep 30, 2011 38.15M sh
Shares Diluted Q3 2011 · Sep 30, 2010 38.51M sh
Shares Diluted Q3 2011 · Sep 30, 2010 38.38M sh
Current Liabilities Q3 2011 · Sep 30, 2011 $56.83M
Current Liabilities Q3 2011 · Dec 31, 2010 $55.01M
Total Liabilities Q3 2011 · Sep 30, 2011 $57.57M
Total Liabilities Q3 2011 · Dec 31, 2010 $58.44M
Current Assets Q3 2011 · Sep 30, 2011 $159.91M
Current Assets Q3 2011 · Dec 31, 2010 $108.26M
Total Assets Q3 2011 · Sep 30, 2011 $198.45M
Total Assets Q3 2011 · Dec 31, 2010 $141.54M
Eps Diluted Q3 2011 · Sep 30, 2011 $0.22
Eps Diluted Q3 2011 · Sep 30, 2011 $0.57
Eps Diluted Q3 2011 · Sep 30, 2010 $0.18
Eps Diluted Q3 2011 · Sep 30, 2010 $0.48
Eps Basic Q3 2011 · Sep 30, 2011 $0.22
Eps Basic Q3 2011 · Sep 30, 2011 $0.57
Eps Basic Q3 2011 · Sep 30, 2010 $0.18
Eps Basic Q3 2011 · Sep 30, 2010 $0.48
Capex Q3 2011 · Sep 30, 2010 $119.64K
Operating Cash Flow Q3 2011 · Sep 30, 2010 $9.92M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $13.62M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $13.3M
Sga Expense Q3 2011 · Sep 30, 2010 $2.37M
Sga Expense Q3 2011 · Sep 30, 2010 $5.31M
Operating Income Q3 2011 · Sep 30, 2010 $9.48M
Operating Income Q3 2011 · Sep 30, 2010 $25.93M
Gross Profit Q3 2011 · Sep 30, 2010 $13.23M
Gross Profit Q3 2011 · Sep 30, 2010 $34.71M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $39.29M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $99.34M
Revenue Q3 2011 · Sep 30, 2010 $52.53M
Revenue Q3 2011 · Sep 30, 2010 $134.05M